Cointime

PathAI

company

About

PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time.

  • 101 - 250

Highlights

Total Funding Amount
$240M
Funding Rounds
3
Investors
3
Investments
3

Details

Last Funding Type
Series C
Last Funding Money Raised
$165M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2016
Number Of Employee
101 - 250
Operating Status
Active

PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry.

The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time.

The company was founded in 2016 and based in Boston, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$240M
PathAI has raised a total of $240M in funding over 2 rounds. Their latest funding was raised on May 18, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2021 Series C $165M 3 Kaiser Permanente — Detail
Nov 4, 2019 Series B $15M 1 LabCorp — Detail
Apr 17, 2019 Series B $60M 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
3
0
PathAI has made 3 investments. Their most recent investment was on Dec 14, 2022, when Nametag raised $2M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 14, 2022 Nametag
Seed $2M Cryptocurrency —
Oct 18, 2022 Light Protocol
Seed $4.50M Blockchain —
Mar 17, 2021 Syndicate
Seed $1M Cryptocurrency —

Investors

Number of Lead Investors
Number of Investors
2
3
PathAI is funded by 3 investors. Kaiser Permanente and LabCorp are the most recent investors.
Investor Name Lead Investor Funding Round
Kaiser Permanente Yes Series C
LabCorp — Series C
General Catalyst — Series C
Cointime
Content
Company